Intriguingly, XPO1 expression is markedly increased in a wide array of tumour cells, including osteosarcoma, glioma, lung cancer, ovarian cancer, pancreatic cancer, oesophageal cancer, gastric cancer and colorectal cancer (CRC) cells. Here, XPO1 is linked to ovarian cancer.